LVTXLAVA Therapeutics NV

$1.74
$0.00
(0.00%)
Pre-Market
Updated: 12:00 AM EST·Prev Close $1.74
Reported EarningsAug 13
Mkt Cap$45.77M
Vol285,521.00

About

LAVA Therapeutics NV is an immuno-oncology company, which engages in the proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
34

Frequently Asked Questions

What is Market Cap of LAVA Therapeutics NV?
What is the 52-week high for LAVA Therapeutics NV?
What is the 52-week low for LAVA Therapeutics NV?
What is LAVA Therapeutics NV stock price today?
What was LAVA Therapeutics NV stock price yesterday?
What is the PE ratio of LAVA Therapeutics NV?
What is the Price-to-Book ratio of LAVA Therapeutics NV?
What is the 50-day moving average of LAVA Therapeutics NV?
How many employees does LAVA Therapeutics NV have?

Advertisement|Remove ads.